The Angiopoietin Signaling Pathway Is Involved in Inflammatory Processes in Hospitalized COVID-19 Patients
Authors:
- Rachelle P. MendozaRMRachelle P. Mendoza
- Amir MomeniAMAmir Momeni
- Nayanendu SahaNSNayanendu Saha
- Juwairiya ArshiJAJuwairiya Arshi
- Elmer C. GabutanEGElmer C. Gabutan
- Nichole AlejandroNANichole Alejandro
- Alejandro ZurettiAZAlejandro Zuretti
- Prem K. PremsrirutPPPrem K. Premsrirut
- Dimitar B. NikolovDNDimitar B. Nikolov
Open Access
- 8 December 2023
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 11 (12) , 2940
Abstract
The viral agent SARS-CoV-2 clearly affects several organ systems, including the cardiovascular system. Angiopoietins are involved in vascular integrity and angiogenesis. Angiopoietin-1 (Ang1) promotes vessel stabilization, while angiopoietin-2 (Ang2), which is usually expressed at low levels, is significantly elevated in inflammatory and angiogenic conditions. Interleukin-6 (IL-6) is known to induce defective angiogenesis via the activation of the Ang2 pathway. Vasculitis and vasculopathy are some of the defining features of moderate to severe COVID-19-associated systemic disease. We investigated the serum levels of angiopoietins, as well as interleukin-6 levels and anti-SARS-CoV2 IgG titers, in hospitalized COVID-19 patients across disease severity and healthy controls. Ang2 levels were elevated in COVID-19 patients across all severity compared to healthy controls, while Ang1 levels were decreased. The patients with adverse outcomes (death and/or prolonged hospitalization) had relatively lower and stable Ang1 levels but continuously elevated Ang2 levels, while those who had no adverse outcomes had increasing levels of both Ang1 and Ang2, followed by a decrease in both. These results suggest that the dynamic levels of Ang1 and Ang2 during the clinical course may predict adverse outcomes in COVID-19 patients. Ang1 seems to play an important role in controlling Ang2-related inflammatory mechanisms in COVID-19 patients. IL-6 and anti-SARS-CoV2 spike protein IgG levels were significantly elevated in patients with severe disease. Our findings represent an informative pilot assessment into the role of the angiopoietin signaling pathway in the inflammatory response in COVID-19.Keywords
This publication has 29 references indexed in Scilit:
- Interleukin-6 Stimulates Defective AngiogenesisCancer Research, 2015
- Angiopoietin‐2: a multifaceted cytokine that functions in both angiogenesis and inflammationAnnals of the New York Academy of Sciences, 2015
- Tie2 and Eph Receptor Tyrosine Kinase Activation and SignalingCold Spring Harbor Perspectives in Biology, 2014
- Angiopoietin-1 is essential in mouse vasculature during development and in response to injuryJournal of Clinical Investigation, 2011
- Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patientsCritical Care Medicine, 2010
- Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivityCritical Care, 2010
- Insulin-like growth factor-1 receptor activation prevents high glucose-induced mitochondrial dysfunction, cytochrome-c release and apoptosisBiochemical and Biophysical Research Communications, 2009
- Cytokine profile in elderly patients with sepsisIndian Journal of Critical Care Medicine, 2009
- The role of the Angiopoietins in vascular morphogenesisAngiogenesis, 2009
- Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting,during a critical developmental periodDevelopment, 2005